CoreTissue BioEngineering Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series AA

  • Latest Deal Amount
  • $3.93M

  • Investors
  • 14

CoreTissue BioEngineering General Information

Description

Developer of implantable artificial ligaments designed for anterior cruciate ligament reconstruction. The company develops artificial ligaments that are used for the reconstruction of anterior knee cruciate ligaments using decellularized tissue that removes cellular components from biological tissues and then transplants them into the body, enabling patients to have a reconstruction of the anterior knee cruciate ligaments and lead a healthy lifestyle.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 301 Life Science Research Center
  • 1-1-43 Suehirocho, Tsurumi-ku
  • Yokohama, Kanagawa 230-0045
  • Japan
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 301 Life Science Research Center
  • 1-1-43 Suehirocho, Tsurumi-ku
  • Yokohama, Kanagawa 230-0045
  • Japan

CoreTissue BioEngineering Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CoreTissue BioEngineering Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series AA) 10-Nov-2025 $3.93M Completed Clinical Trials - Phase 3
6. Accelerator/Incubator 30-Jul-2024 Completed Generating Revenue
5. Later Stage VC (Series A) 24-Feb-2023 Completed Generating Revenue
4. Accelerator/Incubator 08-Aug-2022 Completed Generating Revenue
3. Accelerator/Incubator 20-Oct-2021 Completed Generating Revenue
2. Seed Round 16-Oct-2019 Completed Generating Revenue
1. University Spin-Out 29-Nov-2016 Completed Startup
To view CoreTissue BioEngineering’s complete valuation and funding history, request access »

CoreTissue BioEngineering Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A preferred
To view CoreTissue BioEngineering’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CoreTissue BioEngineering Patents

CoreTissue BioEngineering Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025158851-A Sterile container lid Pending 05-Apr-2024
JP-7432981-B2 Container for biological tissue storage Active 06-Oct-2021
EP-4327656-A1 Container for storing biological tissue Pending 06-Oct-2021
EP-4327656-A4 Container for storing biological tissue Pending 06-Oct-2021
US-20240246744-A1 Container for storing biological tissue Pending 06-Oct-2021 A01N1/146
To view CoreTissue BioEngineering’s complete patent history, request access »

CoreTissue BioEngineering Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CoreTissue BioEngineering Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mitsui Sumitomo Kaijo Capital Corporate Venture Capital Minority
MMA Investment Limited Corporation Minority
NH Foods Corporation Minority
Waseda University Ventures Venture Capital Minority
Mitsubishi Corporation Minority
You’re viewing 5 of 14 investors. Get the full list »

CoreTissue BioEngineering FAQs

  • When was CoreTissue BioEngineering founded?

    CoreTissue BioEngineering was founded in 2016.

  • Where is CoreTissue BioEngineering headquartered?

    CoreTissue BioEngineering is headquartered in Yokohama, Japan.

  • What is the size of CoreTissue BioEngineering?

    CoreTissue BioEngineering has 25 total employees.

  • What industry is CoreTissue BioEngineering in?

    CoreTissue BioEngineering’s primary industry is Therapeutic Devices.

  • Is CoreTissue BioEngineering a private or public company?

    CoreTissue BioEngineering is a Private company.

  • What is the current valuation of CoreTissue BioEngineering?

    The current valuation of CoreTissue BioEngineering is .

  • What is CoreTissue BioEngineering’s current revenue?

    The current revenue for CoreTissue BioEngineering is .

  • How much funding has CoreTissue BioEngineering raised over time?

    CoreTissue BioEngineering has raised $8.19M.

  • Who are CoreTissue BioEngineering’s investors?

    Mitsui Sumitomo Kaijo Capital, MMA Investment Limited, NH Foods, Waseda University Ventures, and Mitsubishi are 5 of 14 investors who have invested in CoreTissue BioEngineering.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process